Emkay Share & Stock Brokers IPO vs Plethico Pharmaceuticals IPO

Comparison between Emkay Share & Stock Brokers IPO and Plethico Pharmaceuticals IPO.

IPO Details

Emkay Share & Stock Brokers IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Plethico Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Emkay Share & Stock Brokers IPO is up to ₹75.00 Cr whereas the issue size of the Plethico Pharmaceuticals IPO is up to ₹110.00 Cr. The final issue price of Emkay Share & Stock Brokers IPO is ₹120.00 per share and of Plethico Pharmaceuticals IPO is ₹300.00 per share.

 Emkay Share & Stock Brokers IPOPlethico Pharmaceuticals IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹100.00 per share₹280.00 per share
Issue Price (Upper)₹120.00 per share₹300.00 per share
Issue Price (Final)₹120.00 per share₹300.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size62,50,000 shares36,66,667 shares
Fresh Issue Size (Amount)up to ₹75.00 Crup to ₹110.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total62,50,000 shares36,66,667 shares
Issue Size Total (Amount)up to ₹75.00 Crup to ₹110.00 Cr

IPO Timetable

Emkay Share & Stock Brokers IPO opens on Mar 31, 2006, while Plethico Pharmaceuticals IPO opens on Apr 10, 2006. The closing date of Emkay Share & Stock Brokers IPO and Plethico Pharmaceuticals IPO is Apr 07, 2006, and Apr 17, 2006, respectively.

Financials & KPIs

Emkay Share & Stock Brokers IPO P/E ratio is 32.85, as compared to Plethico Pharmaceuticals IPO P/E ratio of .

 Emkay Share & Stock Brokers IPOPlethico Pharmaceuticals IPO
Financials

Company Financials (Restated Consolidated)

Period Ended30 Sep 200531 Mar 200531 Mar 2004
Assets73.9147.3724.24
Total Income19.8623.5214.18
Profit After Tax6.966.544.06
NET Worth29.5922.6316.97
Reserves and Surplus26.0919.1313.47
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Dec 200530 Sep 200530 Sep 2004
Assets366.83353.39279.74
Total Income64.02224.48237.56
NET Worth280.89262.34208.38
Reserves and Surplus250.49254.74200.74
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)97.7797.5
Promoter Shareholding (Post-Issue)72.4687.01
P/E Ratio32.85
Market Cap₹289.80 Cr.₹1022.00 Cr.
ROE
ROCE
Debt/Equity
EPS₹3.65
RoNW28.4821.40

Shares Offered

In the Emkay Share & Stock Brokers IPO Retail Individual Investors (RII) are offered 21,17,500 shares while in Plethico Pharmaceuticals IPO retail investors are offered 21,17,500 shares. Qualified Institutional Buyers (QIB) are offered 30,25,000 shares in Emkay Share & Stock Brokers IPO and 22,00,000 shares in Plethico Pharmaceuticals IPO.

 Emkay Share & Stock Brokers IPOPlethico Pharmaceuticals IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation0 shares0 shares
QIB30,25,000 shares22,00,000 shares
NII9,07,500 shares3,66,667 shares
RII21,17,500 shares11,00,000 shares
Employee2,00,000 shares0 shares
Others
Total62,50,000 shares36,66,667 shares

Bids Received (Subscription)

Emkay Share & Stock Brokers IPO subscribed in total, whereas Plethico Pharmaceuticals IPO subscribed .

Compare with others

Compare: